Cumberland Pharmaceuticals Files Definitive Proxy Statement
Ticker: CPIX · Form: DEFA14A · Filed: Apr 23, 2026 · CIK: 0001087294
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, shareholder-communication
TL;DR
CUMBERLAND PHARMACEUTICALS (CUMBP) FILED PROXY MATERIALS ON 4/23/26. CHECK FOR SHAREHOLDER VOTES.
AI Summary
Cumberland Pharmaceuticals Inc. filed a Definitive Proxy Statement (DEFA14A) on April 23, 2026. The filing includes various exhibits such as the proxy statement itself, and other materials related to shareholder matters. The company is headquartered in Nashville, TN.
Why It Matters
This filing indicates that Cumberland Pharmaceuticals is engaging in formal communication with its shareholders regarding important company matters, likely related to upcoming meetings or proposals.
Risk Assessment
Risk Level: low — A DEFA14A filing is a standard regulatory document for shareholder communication and does not inherently indicate financial risk.
Key Players & Entities
- CUMBERLAND PHARMACEUTICALS INC (company) — Filer
- 0001087294 (company) — CIK number for Cumberland Pharmaceuticals Inc.
- 2026-04-23 (date) — Filing Date
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is used to provide shareholders with definitive proxy materials, which are used to solicit votes for a shareholder meeting.
When was this DEFA14A filed by Cumberland Pharmaceuticals?
This DEFA14A was filed on April 23, 2026.
What is the CIK number for Cumberland Pharmaceuticals Inc.?
The CIK number for Cumberland Pharmaceuticals Inc. is 0001087294.
Where is Cumberland Pharmaceuticals Inc. located?
Cumberland Pharmaceuticals Inc. is located in Nashville, TN, with both mailing and business addresses at 1600 WEST END AVENUE SUITE 1300 NASHVILLE, TN 37203.
What types of documents are included in this filing?
This filing includes the DEFA14A document itself, along with exhibits such as EX-2.1, EX-10.1, EX-99.1, and graphic files.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 23, 2026 regarding CUMBERLAND PHARMACEUTICALS INC (CPIX).